ロード中...
Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
BACKGROUND: In recent years, a plethora of therapeutic agents for ulcerative colitis (UC), especially novel biologics (Bio), have become available. Although it is now possible to use biological drugs, there should be no need for frequently changing medications. To avoid first-pass metabolism in the...
保存先:
| 出版年: | Med Sci Monit |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scientific Literature, Inc.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939661/ https://ncbi.nlm.nih.gov/pubmed/31865359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.918562 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|